{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:12Z","timestamp":1792425732105,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009259","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:45:18Z","timestamp":1513172718000},"page":"e9259","source":"Crossref","is-referenced-by-count":11,"title":["Targeted therapy with apatinib in a patient with relapsed small cell lung cancer"],"prefix":"10.1097","volume":"96","author":[{"given":"Jun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-117-20210226","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/13543784.2014.951434","article-title":"Ganitumab for the treatment of small-cell lung cancer","volume":"23","author":"Mart\u00ednez","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"R2-117-20210226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/OTT.S119714","article-title":"Advances in antiangiogenic treatment of small-cell lung cancer","volume":"10","author":"Lu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"R3-117-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13577-016-0149-3","article-title":"Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1","volume":"30","author":"Ito","year":"2017","journal-title":"Hum Cell"},{"key":"R4-117-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hoc.2016.08.005","article-title":"Advances in small cell lung cancer","volume":"31","author":"Kalemkerian","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"R5-117-20210226","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"R6-117-20210226","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-14-2958","article-title":"Small cell lung cancer: will recent progress lead to improved outcomes?","volume":"21","author":"Pietanza","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R7-117-20210226","doi-asserted-by":"crossref","first-page":"389","DOI":"10.21037\/tlcr.2016.08.04","article-title":"Targeting angiogenesis in small cell lung cancer","volume":"5","author":"Stratigos","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"R8-117-20210226","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1634\/theoncologist.2015-0523","article-title":"The future of immunotherapy in the treatment of small cell lung cancer","volume":"21","author":"Horn","year":"2016","journal-title":"Oncologist"},{"key":"R9-117-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10456-012-9268-y","article-title":"Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression","volume":"15","author":"Zhou","year":"2012","journal-title":"Angiogenesis"},{"key":"R10-117-20210226","first-page":"123","article-title":"Clinical advances in the development of novel VEGFR2 inhibitors","volume":"2","author":"Fontanella","year":"2014","journal-title":"Ann Transl Med"},{"key":"R11-117-20210226","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-117-20210226","doi-asserted-by":"crossref","first-page":"17220","DOI":"10.18632\/oncotarget.7948","article-title":"Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"R13-117-20210226","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.2147\/DDDT.S97235","article-title":"Apatinib for molecular target therapy in tumor","volume":"13","author":"Zhang","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"R14-117-20210226","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"key":"R15-117-20210226","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.2147\/OTT.S94745","article-title":"Next-generation EGFR\/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R16-117-20210226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/TCRM.S104343","article-title":"Update on targeted therapies for advanced non- small cell lung cancer: nivolumab in contex","volume":"13","author":"Le","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"R17-117-20210226","first-page":"e5","article-title":"FDA Approval Summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements","volume":"19","author":"Kazandjian","year":"2014","journal-title":"Oncotarget"},{"key":"R18-117-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-319-24932-2_9","article-title":"Personalized therapy of small cell lung cancer","volume":"890","author":"Schneider","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"R19-117-20210226","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S1010-7940(02)00112-4","article-title":"Small cell lung carcinoma (SCLC): the angiogenic phenomenon","volume":"21","author":"Lucchi","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"R20-117-20210226","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:47:49Z","timestamp":1620960469000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712150-00117"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009259","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}